Christie Fanton - Concepedia

Concepedia

Author

Christie Fanton

Nektar Therapeutics (United States)

Also Known As

C Fanton, C. Fanton, C. P. Fanton, Christie Fanton, Christie P. Fanton

65

Publications

1.2K

Citations

15

H-Index

38

Concepts

All Affiliations

Nektar Therapeutics (United States)The University of Texas MD Anderson Cancer Center University of New Haven Novartis (Switzerland)Novartis (United States)

CF

About

Christie Fanton is an author at Nektar Therapeutics (United States) specializing in medicine, tumor microenvironment, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	322
2	Cell Biology	3	3	278
3	Natural Sciences	1	1	149
4	Biochemistry	1	1	149
5	Biomedical Engineering	1	1	110

Christie Fanton

×

17

Publications

1.2K

Citations

15

H-Index

	Year	Citations
Bempegaldesleukin (NKTR-214) plus Nivolumab in Patients with Advanced Solid Tumors: Phase I Dose-Escalation Study of Safety, Efficacy, and Immune Activation (PIVOT-02) Adi Diab, Nizar M. Tannir, Salah-Eddine Bentebibel, Cancer Discovery	2020	231
A First-in-Human Study and Biomarker Analysis of NKTR-214, a Novel IL2Rβγ-Biased Cytokine, in Patients with Advanced or Metastatic Solid Tumors Salah-Eddine Bentebibel, Michael E. Hurwitz, Chantale Bernatchez, Cancer Discovery	2019	228
The 31-kDa precursor of interleukin 1 alpha is myristoylated on specific lysines within the 16-kDa N-terminal propiece. Frazier T. Stevenson, Stuart L. Bursten, Christie Fanton, Proceedings of the National Academy of Sciences ImmunologyImmunologic Mechanism31-Kda Precursor16-Kda N-terminal PropieceInflammation	1993	149
Induction of Tubulogenesis in Telomerase-Immortalized Human Microvascular Endothelial Cells by Glioblastoma Cells Eleni Venetsanakos, Amer M. Mirza, Christie Fanton, Experimental Cell Research AngiogenesisGliomaBiological MicroenvironmentsVascular BiologyBiomedical Engineering	2002	110
Pan-PIM Kinase Inhibition Provides a Novel Therapy for Treating Hematologic Cancers Pablo D. García, John L. Langowski, Yingyun Wang, Clinical Cancer Research	2014	110
Preclinical Antitumor Activity of a Novel Anti–c-KIT Antibody–Drug Conjugate against Mutant and Wild-type c-KIT–Positive Solid Tumors Tinya J. Abrams, Anu Connor, Christie Fanton, Clinical Cancer Research	2018	65
Dual Growth Arrest Pathways in Astrocytes and Astrocytic Tumors in Response to Raf-1 Activation Christie Fanton, Martin McMahon, Russell O. Pieper Journal of Biological Chemistry	2001	57
NKTR-358: A novel regulatory T-cell stimulator that selectively stimulates expansion and suppressive function of regulatory T cells for the treatment of autoimmune and inflammatory diseases Neha Dixit, Christie Fanton, John L. Langowski, Journal of Translational Autoimmunity	2021	49
Selective expansion of regulatory T cells by NKTR-358 in healthy volunteers and patients with systemic lupus erythematosus Christie Fanton, Richard Furie, Vishala Chindalore, Journal of Translational Autoimmunity	2022	32
Confluence-induced alterations in CpG island methylation in cultured normal human fibroblasts R. O. Pieper, K. A. Lester, Christie Fanton Nucleic Acids Research	1999	22

Page 1